Farnesyltransferase inhibitors and anti-Ras therapy

Breast Cancer Research and Treatment

Volumn 38, Issue 1, 1996, Pages 75-83

  Gibbs, Jackson B ^a   Kohl, Nancy E ^a   Koblan, Kenneth S ^a   Omer, Charles A ^a   Sepp Lorenzino, Laura ^b   Rosen, Neal ^b   Anthony, Neville J ^a   Conner, Michael W ^a   DeSolms, S Jane ^a   Williams, Theresa M ^a   Graham, Samuel L ^a   Hartman, George D ^a   Oliff, Allen ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Cancer chemotherapy; Mitogenic signal transduction; Oncogenes

Indexed keywords

CELL PROTEIN; CYSTEINE; ENZYME INHIBITOR; FARNESYL TRANS TRANSFERASE; N [2 [2 (2 AMINO 3 MERCAPTOPROPYLAMINO) 3 METHYLPENTYLOXY] 3 PHENYLPROPIONYL]METHIONINE SULFONE; N [2 [2 (2 AMINO 3 MERCAPTOPROPYLAMINO) 3 METHYLPENTYLOXY] 3 PHENYLPROPIONYL]METHIONINE SULFONE METHYL ESTER; ONCOPROTEIN; RAS PROTEIN;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; CANCER CHEMOTHERAPY; CARBOXY TERMINAL SEQUENCE; CELL CULTURE; CELL DIFFERENTIATION; CELL GROWTH; CELL MEMBRANE; CELL TRANSFORMATION; CHEMICAL STRUCTURE; CONFERENCE PAPER; HUMAN; HUMAN CELL; NONHUMAN; ONCOGENE RAS; PRIORITY JOURNAL; PROTEIN PROCESSING; PROTEIN SYNTHESIS; RAT; SIGNAL TRANSDUCTION;

ALKYL AND ARYL TRANSFERASES; ANIMALS; ANTINEOPLASTIC AGENTS; ENZYME INHIBITORS; FARNESYLTRANSTRANSFERASE; GUANOSINE TRIPHOSPHATE; HUMANS; RAS PROTEINS; TRANSFERASES;

EID: 9044237262     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01803786     Document Type: Conference Paper

References (29)

1. Lowy DR, Willumsen BM: Function and regulation of Ras. Annu Rev Biochem 62:851-891, 1993
2. McCormick F: Activators and effectors of ras p21 proteins. Curr Opin Genetics Devel 4:71-76, 1994
3. Prendergast GC, Gibbs JB: Pathways of Ras function. Adv Cancer Res 62:19-64, 1993
4. Clarke S: Protein isoprenylation and methylation at carboxyl-terminal cysteine residues. Annu Rev Biochem 61:355-386, 1992
5. Cox AD, Der CJ: Protein prenylation: more than just glue? Curr Opin Cell Biol 4:1008-1016, 1992
6. Gibbs JB: Ras C-terminal processing enzymes - new drug targets? Cell 65:1-4, 1991
7. Rodriguez-Viciana P, Warne PH, Dhand R, Vanhaesbroeck B, Gout I, Fry MJ, Waterfield MD, Downward J: Phosphatidylinositol 3-OH kinase as a direct target of Ras. Nature 370:527-532, 1994
8. Bollag G, McCormick F: Regulators and effectors of ras proteins. Annu Rev Cell Biol 7:601-632, 1991
9. ras with GAP, exchange factors, and its biological effector target. J Biol Chem 268: 9157-9160, 1993
10. Wittinghofer A, Pai EF: The structure of Ras protein: a model for a universal molecular switch. Trends Biochem Sci 16:382-387, 1991
11. Gibbs JB: Pharmacological probes of Ras function. Semin Cancer Biol 3:383-390, 1992
12. Warne PH, Rodriguez-Viciana P, Downward J: Direct interaction of Ras and the amino-terminal domain of Raf-1 in vitro. Nature 364:352-355, 1993
13. Pawson T, Gish GD: SH2 and SH3 domains: from structure to function. Cell 71:359-362, 1992
14. Chen W-J, Moomaw JF, Overton L, Kost TA, Casey PJ: High level expression of mammalian protein farnesyltransferase in a baculovirus system: the purified protein contains zinc. J Biol Chem 268:9675-9680, 1993
15. Omer CA, Krai AM, Diehl RE, Prendergast GC, Powers S, Allen CM, Gibbs JB, Kohl NE: Characterization of recombinant human farnesyl-protein transferase; cloning, expression, farnesyl diphosphate binding, and functional homology with yeast prenyl-protein transferases. Biochemistry 32:5167-5176, 1993
16. Reiss Y, Scabra MC, Armstrong SA, Slaughter CA, Goldstein JL, Brown MS: Nonidentical subunits of p21H-ras farnesyltransferase: peptide binding and farnesyl diphosphate carrier functions. J Biol Chem 266:10672-10677, 1991
17. Pompliano DL, Rands E, Schaber MD, Mosser SD, Anthony NJ, Gibbs JB: Steady-state kinetic mechanism of Ras farnesyl-protein transferase. Biochemistry 31:3800-3807, 1992
18. Patel DV, Gordon EM, Schmidt RJ, Weller HN, Young MG, Zahler R, Barbacid M, Carboni JM, Gullo-Brown JL, Hunihan L, Ricca C, Robinson S, Seizinger BR, Tuomari AV, Manne V: Phosphinyl acid-based bisubstrate analog inhibitors of Ras farnesyl-proiein transferase. J Med Chem 38:435-442, 1995
19. Gibbs JB, Oliff A, Kohl NE: Farnesyltransferase inhibitors: Ras research yields a potential cancer therapeutic. Cell 77: 175-178, 1994
20. Graham SL, deSolms SJ, Giuliani EA, Kohl NE, Mosser SD, Oliff AI, Pompliano DL, Rands E, Breslin MJ, Deana AA, Garsky VM, Scholz TH, Gibbs JB, Smith RL: Pseudopeptide inhibitors of Ras farnesyl-protein transferase. J Med Chem 37:725-732, 1994
21. Tamanoi F: Inhibitors of Ras farnesyltransferase. Trends Biochem Sci 18:349-353, 1993
22. Gibbs JB, Pompliano DL, Mosser SD, Rands E, Lingham RB, Singh SB, Scolnick EM, Kohl NE, Oliff A: Selective inhibition of farnesyl-protein transferase blocks Ras processing in vivo. J Biol Chem 268: 7617-7620, 1993
23. Hara M, Akasaka K, Akinaga S, Okabe M, Nakano H, Gomez R, Wood D, Uh M, Tamanoi F: Identification of Ras farnesyltransferase inhibitors by microbial screening. Proc Natl Acad Sci USA 90:2281-2285, 1993
24. Kohl NE, Mosser SD, deSolms SJ, Giuliani EA, Pompliano DL, Graham SL, Smith RL, Scolnick EM, Oliff A, Gibbs JB: Selective inhibition of ras-dependent transformation by a farnesyltransferase inhibitor. Science 260:1934-1937, 1993
25. Kohl NE, Wilson FR, Mosser SD, Giuliani E, deSolms SJ, Conner MW, Anthony NJ, Holtz WJ, Gomez RP, Lee T-J, Smith RL, Graham SL, Hartman GD, Gibbs JB, Oliff A: Protein farnesyltransferase inhibitors block the growth of ras-dependent tumors in nude mice. Proc Natl Acad Sci USA 91:9141-9145, 1994
26. James GL, Goldstein JL, Brown MS, Rawson TE, Somers TC, McDowell RS, Crowley CW, Lucas BK, Levinson AD, Marsters JC Jr: Benzodiazepine peptidomimetics: potent inhibitors of Ras farnesylation in animal cells. Science 260: 1937-1942, 1993
27. Prendergast GC, Davide JP, deSolms SJ, Giuliani EA, Graham SL, Gibbs JB, Oliff A, Kohl NE: Farnesyltransferase inhibition causes morphological reversion of ras-transformed cells by a complex mechanism that involves regulation of the actin cytoskeleton. Mol Cell Biol 14: 4193-4202, 1994
28. James GL, Goldstein JL, Pathak RK, Anderson RGW, Brown MS: PXF, a prenylated protein of peroxisomes. J Biol Chem 269:14182-14190, 1994
29. Shirasawa S, Furuse M, Yokoyama N, Sasazuki T: Altered growth of human colon cancer cell lines disrupted at activated Ki-ras. Science 260:85-88, 1993